Ly49 and CD94/NKG2: developmentally regulated expression and evolution.

Area of Science:

• Immunology
• Cell Biology
• Developmental Biology

Background:

• Murine natural killer (NK) cells express MHC class I-specific receptors, primarily the Ly49 family and CD94/NKG2 heterodimers.
• Receptor repertoire diversity in NK cells is established during development, with fetal NK cells exhibiting limited diversity compared to adult populations.
• These receptors also function on T cells, but their expression patterns differ significantly between NK and T cells, highlighting developmental regulation.

Purpose of the Study:

• To investigate the developmental regulation of Ly49 and CD94/NKG2 receptor expression in murine NK cells.
• To explore the mechanisms governing Ly49 gene expression by examining putative regulatory regions.
• To understand the evolutionary trajectory of Ly49 genes by comparing primate species.

Main Methods:

• Analysis of receptor repertoire diversity in fetal and adult murine NK cells.
• In vitro differentiation studies of NK cells from bone marrow progenitors and embryonic stem cells.
• Examination of DNA sequences in putative regulatory regions of Ly49 genes.
• Comparative genomic analysis of Ly49 genes across primate species.

Main Results:

• NK cell receptor expression is developmentally regulated, with distinct patterns observed in fetal versus adult populations.
• NK cells acquire Ly49 and CD94/NKG2 receptors in an orderly fashion during differentiation.
• Putative regulatory regions of Ly49 genes with different expression patterns show conserved sequences.
• A functional Ly49 gene was identified in baboons, indicating a recent evolutionary loss in the human lineage.

Conclusions:

• The expression of Ly49 and CD94/NKG2 receptors on NK cells is tightly controlled during development.
• Mechanisms regulating Ly49 expression may involve conserved sequences in their regulatory regions.
• The Ly49 gene family has undergone recent functional extinction in the human lineage, offering insights into immune gene evolution.